About this trial
Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness has a positive effect on cancer survivors social, emotional and physical well-being as well as their epigenetics. Epigenetics is how the environment can effect your genes; not by changing our DNA, but by turning genes on or off.
Eligibility criteria
Qualifiers
Adults over 18 years old
Primary diagnosis: Lung Cancer, Colon Cancer and Non-Hodgkin's lymphoma (NHL)
Six months post cancer-directed treatment (chemotherapy, targeted and immunotherapy). Patients with active disease (e.g. metastatic colorectal cancer) who are not receiving any cancer-directed treatment are eligible.
Able to provide a saliva sample
Disqualifiers
Adults with primary anal and/or primary rectal cancer.
Adult cancer survivors who are currently on an active treatment regimen.
Oral or any pathological conditions that can limit the ability to produce saliva.
Unable to participate in full length study period and follow up thereafter.
Trial design
Treatments tested in this trial
- Oncology-informed yoga
- SMART
Treatment groups
Sponsors and collaborators
Barbara Nemesure
Lead sponsor
Stony Brook University
Sponsor institution